Ogen Interactions
There are 234 drugs known to interact with Ogen (estropipate), along with 17 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 17 are major, 198 are moderate, and 19 are minor.
- View all 234 medications that may interact with Ogen
- View Ogen alcohol/food interactions (3)
- View Ogen disease interactions (17)
Most frequently checked interactions
View interaction reports for Ogen (estropipate) and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- Amerge (naratriptan)
- amitriptyline
- Atarax (hydroxyzine)
- Benadryl (diphenhydramine)
- Celexa (citalopram)
- Crestor (rosuvastatin)
- Cymbalta (duloxetine)
- Depo Provera (medroxyprogesterone)
- Exelon (rivastigmine)
- Flonase (fluticasone nasal)
- fluoxetine
- furosemide
- hydrochlorothiazide
- Inderal (propranolol)
- Lescol (fluvastatin)
- Lozol (indapamide)
- Lyrica (pregabalin)
- MSIR (morphine)
- Nexium (esomeprazole)
- Premphase (conjugated estrogens / medroxyprogesterone)
- Prempro (conjugated estrogens / medroxyprogesterone)
- Prilosec (omeprazole)
- Propecia (finasteride)
- Protonix (pantoprazole)
- Questran (cholestyramine)
- Singulair (montelukast)
- Synthroid (levothyroxine)
- Tegretol (carbamazepine)
- Topamax (topiramate)
Ogen alcohol/food interactions
There are 3 alcohol/food interactions with Ogen (estropipate).
Ogen disease interactions
There are 17 disease interactions with Ogen (estropipate) which include:
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
More about Ogen (estropipate)
- Compare alternatives
- Reviews (4)
- Side effects
- Dosage information
- During pregnancy
- Drug class: estrogens
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.